These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6638558)

  • 1. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin.
    Lowenstein E; Johnston WE; Lappas DG; D'Ambra MN; Schneider RC; Daggett WM; Akins CW; Philbin DM
    Anesthesiology; 1983 Nov; 59(5):470-3. PubMed ID: 6638558
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of protamine-induced catastrophic pulmonary vasoconstriction by prostaglandin E1.
    Whitman GJ; Martel D; Weiss M; Pochanapring A; See WM; Hopeman A; Harken AH; Dauber IM
    Ann Thorac Surg; 1990 Aug; 50(2):303-5. PubMed ID: 2383122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catastrophic vasoconstriction after protamine reversal of heparin anticoagulation in the goat.
    Tominaga R; Smith WA; Harasaki H; Golding LA
    Artif Organs; 1993 Sep; 17(9):819-21. PubMed ID: 8240078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytopenia accompanying a reaction to protamine sulfate.
    Horrow JC
    Can Anaesth Soc J; 1985 Jan; 32(1):49-52. PubMed ID: 3971203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of nitric oxide for managing catastrophic pulmonary vasoconstriction arising from protamine administration.
    Ralley FE
    Anesth Analg; 1999 Mar; 88(3):505-7. PubMed ID: 10071995
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complications associated with the use of protamine sulfate].
    Iavorovskiĭ AG; Meshcheriakov AV
    Anesteziol Reanimatol; 1992; (3):69-72. PubMed ID: 1463245
    [No Abstract]   [Full Text] [Related]  

  • 7. Protamine allergy.
    Horrow JC
    J Cardiothorac Anesth; 1988 Apr; 2(2):225-42. PubMed ID: 17171918
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of catastrophic pulmonary vasoconstriction after protamine administration in cardiac surgery: role of intraoperative transesophageal echocardiography.
    Hiong YT; Tang YK; Chui WH; Das SR
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):727-31. PubMed ID: 18922431
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary microvascular responses to protamine and histamine. Effects of cardiopulmonary bypass.
    Friedman M; Johnson RG; Wang SY; Dai HB; Thurer RL; Weintraub RM; Sellke FW
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1092-9. PubMed ID: 7983878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Catastrophic pulmonary vasoconstriction].
    Rodríguez A; Aguado P; Rubio J; Rojas A; Feijo J; Díaz J; Abad C
    Rev Esp Anestesiol Reanim; 1992; 39(3):194-5. PubMed ID: 1410744
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydrocortisone pretreatment for attenuation of protamine-induced adverse hemodynamic reactions.
    Baraka A; Choueiry P; Taha S; Yazbeck V; Chidiac G; Azar IA; Zughbi J
    J Cardiothorac Vasc Anesth; 1995 Aug; 9(4):481-2. PubMed ID: 7579125
    [No Abstract]   [Full Text] [Related]  

  • 12. Nafamstat mesilate attenuates pulmonary hypertension in heparin-protamine reactions.
    Kreil E; Montalescot G; Greene E; Fitzgibbon C; Robinson D; Chenoweth D; Zapol WM
    J Appl Physiol (1985); 1989 Oct; 67(4):1463-71. PubMed ID: 2793750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The heparin-protamine interaction. A review.
    Carr JA; Silverman N
    J Cardiovasc Surg (Torino); 1999 Oct; 40(5):659-66. PubMed ID: 10596998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin].
    Cao Y; Shioi K; Narumiya C; Aoyama T; Mase T; Nagata Y
    Kyobu Geka; 2000 May; 53(5):390-5. PubMed ID: 10808289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotension and Transient ST Elevation After Reversal of Heparin With Protamine.
    Kanjwal K; Mughal M; Shah I; Madala MC
    Am J Ther; 2019; 26(5):e646-e647. PubMed ID: 30303826
    [No Abstract]   [Full Text] [Related]  

  • 16. Protamine reactions, explosive mediator release, and pulmonary vasoconstriction.
    Lowenstein E; Zapol WM
    Anesthesiology; 1990 Sep; 73(3):373-5. PubMed ID: 2393123
    [No Abstract]   [Full Text] [Related]  

  • 17. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
    Stefaniszyn HJ; Novick RJ; Salerno TA
    J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of twice catastrophic pulmonary vasoconstriction-type shock induced with protamine sulfate].
    Inoue S; Miyashita T; Kuro M
    Masui; 1997 Jul; 46(7):987-90. PubMed ID: 9251520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5a and thromboxane generation associated with pulmonary vaso- and broncho-constriction during protamine reversal of heparin.
    Morel DR; Zapol WM; Thomas SJ; Kitain EM; Robinson DR; Moss J; Chenoweth DE; Lowenstein E
    Anesthesiology; 1987 May; 66(5):597-604. PubMed ID: 3495208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
    Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E
    Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.